Assessment of type of pain and other clinical data in relation to neuropathy
| Degree of neuropathy assessed by the TCSS . | n (%) . | n (%) with PDPN or mixed pain . | A1C (%) (means ± SD) . | Duration of diabetes (years) (means ± SD) . |
|---|---|---|---|---|
| No neuropathy (0–5) | 107 (39.8) | 8 (7.4) | 6.89 ± 1.3 | 6.09 ± 5.6 |
| Mild neuropathy (6–8) | 98 (36.4) | 20 (20.1) | 7.26 ± 1.3 | 8.79 ± 6.5 |
| Moderate neuropathy (9–11) | 37 (13.8) | 24 (64.9) | 7.49 ± 1.3 | 9.08 ± 8.5 |
| Severe neuropathy (12+) | 28 (10.0) | 19 (67.9) | 8.13 ± 1.9 | 11.60 ± 8.4 |
| Total | 269 (100) | 71 (26.4) | 7.26 ± 1.43 | 8.03 ± 6.9 |
| Degree of neuropathy assessed by the TCSS . | n (%) . | n (%) with PDPN or mixed pain . | A1C (%) (means ± SD) . | Duration of diabetes (years) (means ± SD) . |
|---|---|---|---|---|
| No neuropathy (0–5) | 107 (39.8) | 8 (7.4) | 6.89 ± 1.3 | 6.09 ± 5.6 |
| Mild neuropathy (6–8) | 98 (36.4) | 20 (20.1) | 7.26 ± 1.3 | 8.79 ± 6.5 |
| Moderate neuropathy (9–11) | 37 (13.8) | 24 (64.9) | 7.49 ± 1.3 | 9.08 ± 8.5 |
| Severe neuropathy (12+) | 28 (10.0) | 19 (67.9) | 8.13 ± 1.9 | 11.60 ± 8.4 |
| Total | 269 (100) | 71 (26.4) | 7.26 ± 1.43 | 8.03 ± 6.9 |